P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE

Bibliographic Details
Main Authors:	N. Martin, A. Xu, N. Stong, J. Rytlewski, O. Finney, T. Campbell, W. Pierceall, E. Flynt, E. Thompson, S. Kaiser
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846348.62497.10

Internet